Do recipients of the first dose of the Pfizer/BioNTech vaccine in December have a legal case against the UK government’s decision to postpone their second dose?

Abstract

The Covid-19 pandemic in the UK has been greatly worsened by the mutation of the virus, which began in the South East and was rapidly spreading and in danger of overwhelming the NHS as hospital admissions and deaths continued to rise. In consequence, the Chief Medical Officers of all four nations supported the UK government’s sudden decision to delay the second dose of the Pfizer/BioNtech and Oxford/AstraZeneka vaccines for 12 weeks (instead of 3) so that more people in the most vulnerable population groups would receive a first dose and some immunity sooner. The expectation is that this strategy would reduce hospital admissions and deaths. This article considers key medical and legal issues arising from this decision and discusses inter alia rationing of scarce resources, fairness, whether it is for the greater good, consent, individual human rights, negligence and claims for potential or actual injury.

Keywords

MHRA JCVI Covid-19 Pfizer/ BioNTech consent,negligence vaccine Oxford AstraZeneka

Get full access to this article

View all access options for this article.

References

Press release MHRA. Available at: https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine (accessed 30 January 2021).

Pollack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine 2020; 383: 2603--2615.

Anand JK. Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows. Rapid Response BMJ 2020; 371: m4826.

Voysey M, Clemens SA, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCov-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa and the U.K. Lancet 2021; 397: 99--111.

Statement from the UK Chief Medical Officers on the prioritisation of first doses of COVID-19 vaccines. Available at: https://www.gov.uk/government/news/statement-from-the-uk-chief-medical-officers-on-the-prioritisation-of-first-doses-of-covid-19-vaccines (accessed 30 January 2021).

Stephens S, Lawson E and Powis S. Publications approval reference C001559. Available at: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/12/C0994-System-letter-COVID-19-vaccination-deployment-planning-30-December-2020.pdf (accessed 30 January 2021).

Neville S and Mancini DP. UK's chief medical officers warn over vaccine availability. Financial Times, 31 December 2020. Available at: https://www.ft.com/content/d97c72c5-ed23-4c2b-bf1c-9cc10b21f007 (accessed 30 January 2021).

BMA Press Release. BMA says decision to delay follow-up dose of Pfizer vaccine `grossly unfair' to thousands of at-risk patients in England, as appointments are rescheduled, 31 December 2020. Available at: https://www.bma.org.uk/bma-media-centre/bma-says-decision-to-delay-follow-up-dose-of-pfizer-vaccine-grossly-unfair-to-thousands-of-at-risk-patients-in-england-as-appointments-are-rescheduled (accessed 30 January 2021).

NHS website. Overview. Consent to treatment. Available at: https://www.nhs.uk/conditions/consent-to-treatment/ (accessed 30 January 2021).